Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelic Stock News stories for the week of April 13th – 19th, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view full article.
Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FRA: 496) is growing a vertically integrated Psychedelic drug company. Champignon’s competitors such as MindMed (NEO: MMED) (OTC: MMEDF) (FRA: BGHM), are using different Psychedelics to treat different disorders, leaving Champignon more room to operate.
Hollister Biosciences (CSE: HOLL) (OTC: HSTRF) (FRA: HOB) is on a roll, and the investing community is finally giving the company the attention it rightfully deserves. Since bottoming at the start of April, HOLL stock has soared over 212% off its lows and shows no signs of slowing down.
Shares of Aurora Cannabis (TSX: ACB) (NYSE: ACB) (FRA: 21P) plummeted after the Edmonton, Canada-based company announced that it will renew its at-the-market offering of up to $350 million in stock and complete a board-approved 1-for-12 reverse stock split.
Canopy Growth (TSX: WEED) (NYSE: CGC) (FRA: 11L1) announced global operational changes that it said are intended to improve production, balance supply and demand and enhance overall efficiencies.
Carl Saling, CEO of Hollister Biosciences (CSE: HOLL) (OTC: HSTRF) (FRA: HOB) and Venom Extracts CEO Mason Cave sat down with TCI host Alyssa Boston (Miss Universe Canada 2019 + Cannabis Crusader) to discuss the recent merger of their companies.
Mr. Bailey is the former president of Red Bull Canada and will now lead Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FRA: 496) marketing, distribution and commercialization of the company’s Novo Formulations-branded novel delivery systems for the pharmaceutical, nutraceutical and Psychedelic medicine industries.
Recently, short-seller Grizzly Research released a 36-page report highlighting the many ways it believes Innovative Industrial Properties (NYSE: IIPR) (FRA: 1IK) is worse than WeWork. The primary gist of Grizzly’s report is that IIPR has acquired a low-quality portfolio of assets in two respects.
Cannabis company HEXO Corp. (TSX: HEXO) (NYSE: HEXO) (FRA: 74H) is enhancing its collaboration with Molson Coors (TSX: TPX.A) (NYSE: TAP) (FRA: NY7). Hexo announced that the joint venture Truss CBD USA will now produce non-alcohol hemp-derived CBD beverages in the Colorado market.